bioRxivPharmacology & ToxicologyPreprint
The effect of ciprofloxacin and gentamicin on wound healing in ex vivo sheep cornea model
Abstract
PurposeOur objective was to assess the efficacy of an ex vivo sheep corneal model as an alternative for live animal testing in screening drug cytotoxicity. In pursuit of this goal, we investigated the impact of two commonly used topical antibiotics, ciprofloxacin and gentamicin, on wound healing. Furthermore, we examined different antibiotic dosages and dosing regimens to understand their effects comprehensively. MethodsThe epithelium on ex vivo sheep corneas was removed with a scalpel, and the area was treated with ciprofloxacin (0.1, 0.3, and 1 mg mL-1), gentamicin (0.25, 1, and 3 mg mL-1), or phosphate-buffered saline (control). The corneas were exposed to treatments continuously or twice daily for ten minutes. Wound closure was observed by fluorescein retention and histological staining. ResultsUntreated corneas healed within 41 hours. Continuous exposure to both ciprofloxacin and gentamicin significantly reduced the corneal healing ability in a time- and concentration-dependent manner. Overall, ciprofloxacin was found to be more toxic than gentamycin. However, this model showed that the corneal epithelium could heal effectively when both antibiotics were administered intermittently. ConclusionCiprofloxacin demonstrated greater inhibition of wound healing compared to gentamicin, aligning with in vivo studies. The administration of drops several times daily mitigated the toxic effects of antibiotics. The ex vivo sheep wound healing model holds promise as an alternative approach to in vivo toxicity testing, enabling the swift evaluation of novel antimicrobial treatments and eye drop additives.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Increased tolerance to commonly used antibiotics in a Pseudomonas aeruginosa ex vivo porcine keratitis model
K. Okurowska, E. Karunakaran, P. Monk·bioRxiv·Aug 10, 2023
- Stable topical application of antimicrobials using plumbing rings in an ex vivo porcine corneal infection model
Daniel M. Foulkes, Keri McLean, … Stephen B. Kaye·PLoS ONEPeer-reviewed·Apr 3, 2025
- A novel ex vivo bovine corneal infection and clearance model for Neisseria gonorrhoeae, Staphylococcus aureus, and Pseudomonas aeruginosa.
F. U. Ukachukwu, R. Alany, L. A. Snyder·bioRxiv·Jul 5, 2023
- Trade-offs between antiseptic cytotoxicity and efficacy in a human ex vivo wound contamination model
- Topical Formulation of Repurposed FDA-Approved Compounds Inhibits Pseudomonas aeruginosa ExoU and Improves Corneal Infection Outcomes
Daniel M. Foulkes, David Garth Fernig, … Stephen B. Kaye·PLoS PathogensPeer-reviewed·Aug 3, 2026
- Cefiderocol: A new and effective topical monotherapy treatment for experimental extensively-drug resistant Pseudomonas aeruginosa keratitis
E. G. Romanowski, S. M. Mumpers, … R. M. Q. Shanks·bioRxiv·Aug 31, 2023